Total Payments
$51,086
2024 Payments
$889.20
Companies
37
Transactions
432
Medicare Patients
1,547
Medicare Billing
$362,158
Payment Breakdown by Category
Other$32,319 (63.3%)
Food & Beverage$11,877 (23.2%)
Travel$6,718 (13.2%)
Research$125.00 (0.2%)
Education$47.59 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $32,319 | 10 | 63.3% |
| Food and Beverage | $11,877 | 391 | 23.2% |
| Travel and Lodging | $6,718 | 24 | 13.2% |
| Unspecified | $125.00 | 1 | 0.2% |
| Education | $47.59 | 6 | 0.1% |
Payments by Type
General
$50,961
431 transactions
Research
$125.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $43,237 | 108 | $0 (2024) |
| Lilly USA, LLC | $1,215 | 60 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,057 | 54 | $0 (2024) |
| ABBVIE INC. | $818.64 | 35 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $655.93 | 17 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $531.32 | 19 | $0 (2021) |
| Indivior Inc. | $457.71 | 9 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $335.52 | 23 | $0 (2022) |
| Abbott Laboratories | $247.37 | 8 | $0 (2024) |
| Dexcom, Inc. | $246.51 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $889.20 | 41 | Lilly USA, LLC ($402.15) |
| 2023 | $753.53 | 35 | Lilly USA, LLC ($259.59) |
| 2022 | $855.22 | 43 | Novo Nordisk Inc ($187.99) |
| 2021 | $1,411 | 62 | Novo Nordisk Inc ($418.82) |
| 2020 | $735.02 | 35 | AstraZeneca Pharmaceuticals LP ($136.03) |
| 2019 | $8,097 | 53 | Novo Nordisk Inc ($6,844) |
| 2018 | $24,429 | 99 | Novo Nordisk Inc ($22,725) |
| 2017 | $13,915 | 64 | Novo Nordisk Inc ($12,805) |
All Payment Transactions
432 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Diabetes Care | ||||||
| 11/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Endocrinology | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Endocrinology | ||||||
| 10/15/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $18.95 | General |
| 10/07/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $22.99 | General |
| Category: Endocrinology | ||||||
| 09/24/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Obesity | ||||||
| 09/17/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $19.55 | General |
| 09/11/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $35.56 | General |
| Category: Endocrinology | ||||||
| 08/13/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: Obesity | ||||||
| 08/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Obesity | ||||||
| 07/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Diabetes | ||||||
| 07/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Cardiology | ||||||
| 06/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Endocrinology | ||||||
| 06/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Endocrinology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Quantitative Testing of Prescriber Knowledge, Attitudes and Behavior about SUBOXONE buprenorphine and naloxone Sublingual Film CIII Safety and Use Information | Indivior Inc. | $125.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 482 | 1,513 | $207,860 | $115,231 |
| 2022 | 6 | 363 | 1,249 | $162,745 | $89,358 |
| 2021 | 7 | 383 | 1,429 | $170,025 | $97,500 |
| 2020 | 6 | 319 | 1,012 | $105,760 | $60,069 |
Total Patients
1,547
Total Services
5,203
Medicare Billing
$362,158
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 653 | $114,275 | $68,045 | 59.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 117 | 234 | $58,500 | $32,356 | 55.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 39 | 39 | $12,675 | $6,654 | 52.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 68 | $7,480 | $5,090 | 68.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 44 | 170 | $5,950 | $2,033 | 34.2% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 52 | 159 | $3,180 | $612.15 | 19.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 21 | 21 | $1,575 | $240.54 | 15.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 44 | 169 | $4,225 | $200.15 | 4.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 493 | $86,275 | $50,890 | 59.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 102 | 230 | $57,500 | $32,758 | 57.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $5,525 | $2,777 | 50.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 38 | 164 | $5,740 | $2,008 | 35.0% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 52 | 184 | $3,680 | $713.80 | 19.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 37 | 161 | $4,025 | $211.63 | 5.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 143 | 603 | $105,150 | $63,109 | 60.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 76 | 136 | $32,250 | $20,112 | 62.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 82 | $9,020 | $6,572 | 72.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 23 | 23 | $7,475 | $4,027 | 53.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 38 | 225 | $7,875 | $2,762 | 35.1% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 45 | 152 | $3,055 | $597.36 | 19.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 36 | 208 | $5,200 | $319.77 | 6.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 131 | 513 | $71,820 | $45,394 | 63.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 61 | 89 | $17,800 | $9,922 | 55.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 17 | 17 | $5,525 | $2,413 | 43.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 35 | 143 | $5,005 | $1,657 | 33.1% |
About Dr. Ian Yip, MD
Dr. Ian Yip, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Woodland Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770503955.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ian Yip, MD has received a total of $51,086 in payments from pharmaceutical and medical device companies, with $889.20 received in 2024. These payments were reported across 432 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($32,319).
As a Medicare-enrolled provider, Yip has provided services to 1,547 Medicare beneficiaries, totaling 5,203 services with total Medicare billing of $362,158. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Woodland Hills, CA
- Active Since 07/20/2006
- Last Updated 02/27/2015
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1770503955
Products in Payments
- Saxenda (Drug) $42,121
- JARDIANCE (Drug) $1,088
- TRULICITY (Drug) $575.75
- FARXIGA (Drug) $463.92
- Ozempic (Drug) $445.93
- INVOKANA (Drug) $403.57
- SUBLOCADE (Drug) $332.71
- Synthroid (Drug) $295.05
- Wegovy (Drug) $282.16
- Tresiba (Drug) $264.72
- TRADJENTA (Drug) $255.83
- XARELTO (Drug) $252.36
- CONTRAVE (Drug) $228.25
- UBRELVY (Drug) $220.00
- LINZESS (Drug) $199.64
- TRINTELLIX (Drug) $191.53
- Vascepa (Drug) $189.80
- AFREZZA (Drug) $184.28
- Dexcom G6 Transmitter (Medical Supply) $182.70
- MOUNJARO (Drug) $159.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Woodland Hills
Sima Hassani, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $630.06
Endocrinology, Diabetes & Metabolism $630.06
Rebecca Weiss, B.s., B.a, B.S., B.A
Endocrinology, Diabetes & Metabolism — Payments: $601.44
Endocrinology, Diabetes & Metabolism $601.44
Mingfei Luo, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $100.10
Endocrinology, Diabetes & Metabolism $100.10
Frederick Ziel, Md, MD
Endocrinology, Diabetes & Metabolism
Endocrinology, Diabetes & Metabolism